Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.025 per share
-
Shares outstanding
-
61.5M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
27.6M
-
Shares change
-
+27.6M
-
Total reported value, excl. options
-
$594M
-
Value change
-
+$594M
-
Number of buys
-
34
-
Price
-
$21.73
Significant Holders of GH Research PLC - Ordinary shares, nominal value $0.025 per share (GHRS) as of Q2 2021
34 filings reported holding GHRS - GH Research PLC - Ordinary shares, nominal value $0.025 per share as of Q2 2021.
GH Research PLC - Ordinary shares, nominal value $0.025 per share (GHRS) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.6M shares
of 61.5M outstanding shares and own 44.85% of the company stock.
Largest 10 shareholders include BVF INC/IL (9.28M shares), RA CAPITAL MANAGEMENT, L.P. (2.98M shares), RTW INVESTMENTS, LP (2.17M shares), ORBIMED ADVISORS LLC (1.43M shares), FMR LLC (1.36M shares), Verition Fund Management LLC (1.34M shares), CITADEL ADVISORS LLC (1.28M shares), VR Adviser, LLC (1.28M shares), BOXER CAPITAL, LLC (1.01M shares), and Logos Global Management LP (724K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.